Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





New Biosensor Detects COVID-19 and SARS-CoV-2 Variants on People's Breath within a Minute

By HospiMedica International staff writers
Posted on 09 Jul 2021
An instant COVID-19 sensor could help transform day-to-day management of the pandemic, protecting frontline workers and the wider community.

RMIT University (Melbourne, Australia) is collaborating with partners including Soterius Pty Ltd. More...
(Melbourne, Australia) on the biosensor, which can detect the presence of tiny amounts of the SARS-CoV-2 virus and its variants. The sensor harnesses nanotechnology-enabled biosensors developed by RMIT researchers at its leading-edge Micro Nano Research Facility. The biosensors technology is covered in a patent application filed by RMIT, with the integrated system the subject of a patent application subsequently filed by Soterius. The successful prototype is now being further developed by Soterius in partnership with RMIT towards commercial release early 2022. The technology will initially be delivered to hospitals, with future applications in other essential worker and high-traffic settings including aged care, quarantine hotels, airports and schools.

Reliable, accurate and non-invasive, the Soterius Scout sensor can deliver results within a minute to provide the all-clear for someone to enter their work environment or alert them if they need to undertake a medical COVID test and self-isolate. Prototype tests conducted at RMIT have revealed that the Soterius Scout biosensor detects SARS-CoV-2 spike protein fragments with impressive accuracy and no false positives. The technology can detect COVID-19 even if someone is asymptomatic. Trials also show the sensor has potential to become a top performing diagnostic tool for respiratory illnesses and it is now being scaled to detect other diseases such as influenza and MERS.

“Our biosensor is so small it can fit on a personal fob card and it’s easy to use – you just need to swipe your card over a reader at checkpoints,” said Soterius co-founder Dr Alasdair Wood. “Importantly, one sensor can detect up to 8 viral strains and our technology can be easily adapted to detect new variants or novel viruses as they emerge. We hope the Soterius Scout biosensor could be a vital tool for managing COVID-19, providing accurate early detection to prevent outbreaks and avoid the need for future lockdowns.”

Related Links:
RMIT University
Soterius Pty Ltd.



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.